{"product_id":"mce-endocrinology-and-rheumatology-for-primary-care-2025","title":"MCE Endocrinology and Rheumatology for Primary Care 2025","description":"\u003cdiv class=\"prod-format\"\u003e\n\u003csection class=\"title\"\u003e\u003csection class=\"titleContent\"\u003e\n\u003cdiv class=\"subtitle\"\u003e\n\u003ch3 data-end=\"240\" data-start=\"193\"\u003eMCE Endocrinology and Rheumatology for Primary Care 2025\u003c\/h3\u003e\n\u003cp data-end=\"240\" data-start=\"193\"\u003eEndocrinology and Rheumatology for Primary Care\u003c\/p\u003e\n\u003ch3 data-end=\"259\" data-start=\"242\"\u003e🗓️ \u003cstrong data-end=\"259\" data-start=\"250\"\u003eDates\u003c\/strong\u003e\n\u003c\/h3\u003e\n\u003cp data-end=\"281\" data-start=\"260\"\u003eOctober 10 – 12, 2025\u003c\/p\u003e\n\u003ch3 data-end=\"302\" data-start=\"283\"\u003e📍 \u003cstrong data-end=\"302\" data-start=\"290\"\u003eLocation\u003c\/strong\u003e\n\u003c\/h3\u003e\n\u003cp data-end=\"388\" data-start=\"303\"\u003eOmni Grove Park Inn – Asheville, North Carolina\u003cbr\u003e(Heritage Ballroom C – Lobby Level)\u003c\/p\u003e\n\u003ch2 data-end=\"1384\" data-start=\"1361\"\u003e\u003cstrong data-end=\"1384\" data-start=\"1367\"\u003eAgenda by Day\u003c\/strong\u003e\u003c\/h2\u003e\n\u003ch3 data-end=\"262\" data-start=\"189\"\u003e\u003cstrong data-end=\"262\" data-start=\"193\"\u003e1 – An Approach to Inflammatory Arthritis – Dr. Simon M. Helfgott\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cp data-end=\"278\" data-start=\"263\"\u003e\u003cstrong data-end=\"278\" data-start=\"263\"\u003eObjectives:\u003c\/strong\u003e\u003c\/p\u003e\n\u003col data-end=\"641\" data-start=\"279\"\u003e\n\u003cli data-end=\"451\" data-start=\"279\"\u003e\n\u003cp data-end=\"451\" data-start=\"282\"\u003eReview the differential diagnosis of inflammatory arthritis conditions, including rheumatoid arthritis, psoriatic arthritis, spondyloarthritis, and crystal arthritides\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"554\" data-start=\"452\"\u003e\n\u003cp data-end=\"554\" data-start=\"455\"\u003eApply diagnostic criteria to identify and differentiate between inflammatory arthritis conditions\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"641\" data-start=\"555\"\u003e\n\u003cp data-end=\"641\" data-start=\"558\"\u003eDevelop a comprehensive management plan for a patient with inflammatory arthritis\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ol\u003e\n\u003chr data-end=\"646\" data-start=\"643\"\u003e\n\u003ch3 data-end=\"728\" data-start=\"648\"\u003e\u003cstrong data-end=\"728\" data-start=\"652\"\u003e2 – Crystal Disease: Gout, Pseudogout and Others – Dr. Simon M. Helfgott\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cp data-end=\"744\" data-start=\"729\"\u003e\u003cstrong data-end=\"744\" data-start=\"729\"\u003eObjectives:\u003c\/strong\u003e\u003c\/p\u003e\n\u003col data-end=\"976\" data-start=\"745\"\u003e\n\u003cli data-end=\"831\" data-start=\"745\"\u003e\n\u003cp data-end=\"831\" data-start=\"748\"\u003eDescribe the presentations for gout, pseudogout and calcific tendonitis syndromes\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"886\" data-start=\"832\"\u003e\n\u003cp data-end=\"886\" data-start=\"835\"\u003eReview the pathophysiology of crystal arthritides\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"976\" data-start=\"887\"\u003e\n\u003cp data-end=\"976\" data-start=\"890\"\u003eDevelop a deeper understanding of the differences in managing acute and chronic gout\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ol\u003e\n\u003chr data-end=\"981\" data-start=\"978\"\u003e\n\u003ch3 data-end=\"1043\" data-start=\"983\"\u003e\u003cstrong data-end=\"1043\" data-start=\"987\"\u003e3 – Diabetes: Workup and Update – Dr. Natasa Janicic\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cp data-end=\"1059\" data-start=\"1044\"\u003e\u003cstrong data-end=\"1059\" data-start=\"1044\"\u003eObjectives:\u003c\/strong\u003e\u003c\/p\u003e\n\u003col data-end=\"1411\" data-start=\"1060\"\u003e\n\u003cli data-end=\"1152\" data-start=\"1060\"\u003e\n\u003cp data-end=\"1152\" data-start=\"1063\"\u003eIdentify the newest data for the identification of patients at risk for type 2 diabetes\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"1216\" data-start=\"1153\"\u003e\n\u003cp data-end=\"1216\" data-start=\"1156\"\u003eDiscuss strategies to prevent or delay the disease process\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"1312\" data-start=\"1217\"\u003e\n\u003cp data-end=\"1312\" data-start=\"1220\"\u003eReview the new guidelines and practice recommendations for nutrition and physical activity\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"1411\" data-start=\"1313\"\u003e\n\u003cp data-end=\"1411\" data-start=\"1316\"\u003eDiscuss pharmacological and non-pharmacological treatment programs for patients with diabetes\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ol\u003e\n\u003chr data-end=\"1416\" data-start=\"1413\"\u003e\n\u003ch3 data-end=\"1479\" data-start=\"1418\"\u003e\u003cstrong data-end=\"1479\" data-start=\"1422\"\u003e4 – Diagnosis of Thyroid Disease – Dr. Natasa Janicic\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cp data-end=\"1495\" data-start=\"1480\"\u003e\u003cstrong data-end=\"1495\" data-start=\"1480\"\u003eObjectives:\u003c\/strong\u003e\u003c\/p\u003e\n\u003col data-end=\"1881\" data-start=\"1496\"\u003e\n\u003cli data-end=\"1607\" data-start=\"1496\"\u003e\n\u003cp data-end=\"1607\" data-start=\"1499\"\u003eIncorporate an interdisciplinary approach to the diagnosis and management of patients with thyroid disease\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"1659\" data-start=\"1608\"\u003e\n\u003cp data-end=\"1659\" data-start=\"1611\"\u003eEvaluate screening methods for thyroid disease\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"1749\" data-start=\"1660\"\u003e\n\u003cp data-end=\"1749\" data-start=\"1663\"\u003eRecognize when to treat subclinical thyroid disease, hypothyroidism, and thyroiditis\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"1881\" data-start=\"1750\"\u003e\n\u003cp data-end=\"1881\" data-start=\"1753\"\u003eDetermine whether the incidence of thyroid disease is increasing at disproportionate rates for different races and ethnicities\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ol\u003e\n\u003chr data-end=\"1886\" data-start=\"1883\"\u003e\n\u003ch3 data-end=\"1928\" data-start=\"1888\"\u003e\u003cstrong data-end=\"1928\" data-start=\"1892\"\u003e5 – Obesity – Dr. Natasa Janicic\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cp data-end=\"1944\" data-start=\"1929\"\u003e\u003cstrong data-end=\"1944\" data-start=\"1929\"\u003eObjectives:\u003c\/strong\u003e\u003c\/p\u003e\n\u003col data-end=\"2165\" data-start=\"1945\"\u003e\n\u003cli data-end=\"2037\" data-start=\"1945\"\u003e\n\u003cp data-end=\"2037\" data-start=\"1948\"\u003eRecognize that obesity is caused by an interaction of environmental and genetic factors\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"2096\" data-start=\"2038\"\u003e\n\u003cp data-end=\"2096\" data-start=\"2041\"\u003eIdentify medical risks and complications with obesity\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"2165\" data-start=\"2097\"\u003e\n\u003cp data-end=\"2165\" data-start=\"2100\"\u003eReview pharmacological and nonpharmacological treatment options\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ol\u003e\n\u003chr data-end=\"2170\" data-start=\"2167\"\u003e\n\u003ch3 data-end=\"2217\" data-start=\"2172\"\u003e\u003cstrong data-end=\"2217\" data-start=\"2176\"\u003e6 – Osteoporosis – Dr. Natasa Janicic\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cp data-end=\"2233\" data-start=\"2218\"\u003e\u003cstrong data-end=\"2233\" data-start=\"2218\"\u003eObjectives:\u003c\/strong\u003e\u003c\/p\u003e\n\u003col data-end=\"2761\" data-start=\"2234\"\u003e\n\u003cli data-end=\"2302\" data-start=\"2234\"\u003e\n\u003cp data-end=\"2302\" data-start=\"2237\"\u003eRecognize and consider the incidence and burden of osteoporosis\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"2392\" data-start=\"2303\"\u003e\n\u003cp data-end=\"2392\" data-start=\"2306\"\u003eDiscuss current clinical guidelines for identification and treatment of osteoporosis\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"2473\" data-start=\"2393\"\u003e\n\u003cp data-end=\"2473\" data-start=\"2396\"\u003eConsistently screen and assess patient risk for development of osteoporosis\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"2520\" data-start=\"2474\"\u003e\n\u003cp data-end=\"2520\" data-start=\"2477\"\u003eEducate patients on prevention strategies\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"2601\" data-start=\"2521\"\u003e\n\u003cp data-end=\"2601\" data-start=\"2524\"\u003eImplement therapeutic decisions based on the latest clinical trial findings\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"2761\" data-start=\"2602\"\u003e\n\u003cp data-end=\"2761\" data-start=\"2605\"\u003eIdentify patients at greater risk of fragility fractures due to probable osteoporosis, and increase index of suspicion in patients based on age and gender\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ol\u003e\n\u003chr data-end=\"2766\" data-start=\"2763\"\u003e\n\u003ch3 data-end=\"2858\" data-start=\"2768\"\u003e\u003cstrong data-end=\"2858\" data-start=\"2772\"\u003e7 – What You Need to Know About Connective Tissue Diseases – Dr. Simon M. Helfgott\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cp data-end=\"2874\" data-start=\"2859\"\u003e\u003cstrong data-end=\"2874\" data-start=\"2859\"\u003eObjectives:\u003c\/strong\u003e\u003c\/p\u003e\n\u003col data-end=\"3163\" data-start=\"2875\"\u003e\n\u003cli data-end=\"3003\" data-start=\"2875\"\u003e\n\u003cp data-end=\"3003\" data-start=\"2878\"\u003eReview connective tissue diseases, such as lupus, scleroderma, myositis and others, and discuss how they present clinically\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"3092\" data-start=\"3004\"\u003e\n\u003cp data-end=\"3092\" data-start=\"3007\"\u003eDetermine the value of selective lab and imaging testing to establish the diagnosis\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"3163\" data-start=\"3093\"\u003e\n\u003cp data-end=\"3163\" data-start=\"3096\"\u003eEvaluate the treatment approach using immunosuppressive therapies\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ol\u003e\n\u003chr data-end=\"3168\" data-start=\"3165\"\u003e\n\u003ch3 data-end=\"3241\" data-start=\"3170\"\u003e\u003cstrong data-end=\"3241\" data-start=\"3174\"\u003e8 – Osteoarthritis and Soft Tissue Pain – Dr. Simon M. Helfgott\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cp data-end=\"3257\" data-start=\"3242\"\u003e\u003cstrong data-end=\"3257\" data-start=\"3242\"\u003eObjectives:\u003c\/strong\u003e\u003c\/p\u003e\n\u003col data-end=\"3676\" data-start=\"3258\"\u003e\n\u003cli data-end=\"3391\" data-start=\"3258\"\u003e\n\u003cp data-end=\"3391\" data-start=\"3261\"\u003eReview the pathophysiology underlying osteoarthritis and soft tissue pain syndromes, such as bursitis, tendonitis, epicondylitis\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"3446\" data-start=\"3392\"\u003e\n\u003cp data-end=\"3446\" data-start=\"3395\"\u003eCompare and contrast their clinical presentations\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"3544\" data-start=\"3447\"\u003e\n\u003cp data-end=\"3544\" data-start=\"3450\"\u003eRecognize the effectiveness of various diagnostic tools, such as X-rays, MRIs, and lab tests\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"3676\" data-start=\"3545\"\u003e\n\u003cp data-end=\"3676\" data-start=\"3548\"\u003eDiscuss pharmacologic and non-pharmacologic interventions available for patients with osteoarthritis or spinal disk conditions\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ol\u003e\n\u003chr data-end=\"3681\" data-start=\"3678\"\u003e\n\u003ch3 data-end=\"3775\" data-start=\"3683\"\u003e\u003cstrong data-end=\"3775\" data-start=\"3687\"\u003e9 – The Challenges of Managing the Immunocompromised Patient – Dr. Simon M. Helfgott\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cp data-end=\"3791\" data-start=\"3776\"\u003e\u003cstrong data-end=\"3791\" data-start=\"3776\"\u003eObjectives:\u003c\/strong\u003e\u003c\/p\u003e\n\u003col data-end=\"4040\" data-start=\"3792\"\u003e\n\u003cli data-end=\"3881\" data-start=\"3792\"\u003e\n\u003cp data-end=\"3881\" data-start=\"3795\"\u003eDiscuss the new generation of biological therapies used to treat autoimmune diseases\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"3943\" data-start=\"3882\"\u003e\n\u003cp data-end=\"3943\" data-start=\"3885\"\u003eRecognize the risks associated with biological therapies\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"4040\" data-start=\"3944\"\u003e\n\u003cp data-end=\"4040\" data-start=\"3947\"\u003eAssess patient-specific factors to optimize the safety and efficacy of biological therapies\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ol\u003e\n\u003chr data-end=\"4045\" data-start=\"4042\"\u003e\n\u003ch3 data-end=\"4135\" data-start=\"4047\"\u003e\u003cstrong data-end=\"4135\" data-start=\"4051\"\u003e10 – Curbside Rheumatology for the Primary Care Provider – Dr. Simon M. Helfgott\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cp data-end=\"4151\" data-start=\"4136\"\u003e\u003cstrong data-end=\"4151\" data-start=\"4136\"\u003eObjectives:\u003c\/strong\u003e\u003c\/p\u003e\n\u003col data-end=\"4369\" data-start=\"4152\"\u003e\n\u003cli data-end=\"4292\" data-start=\"4152\"\u003e\n\u003cp data-end=\"4292\" data-start=\"4155\"\u003eApply case-based learning to identify, evaluate, and manage common rheumatologic conditions effectively within the primary care setting\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"4369\" data-start=\"4293\"\u003e\n\u003cp data-end=\"4369\" data-start=\"4296\"\u003eReview and solidify some of the key clinical areas previously discussed\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ol\u003e\n\u003chr data-end=\"4374\" data-start=\"4371\"\u003e\n\u003ch3 data-end=\"4443\" data-start=\"4376\"\u003e\u003cstrong data-end=\"4443\" data-start=\"4380\"\u003e11 – Female and Male Hormone Potpourri – Dr. Natasa Janicic\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cp data-end=\"4459\" data-start=\"4444\"\u003e\u003cstrong data-end=\"4459\" data-start=\"4444\"\u003eObjectives:\u003c\/strong\u003e\u003c\/p\u003e\n\u003col data-end=\"4633\" data-start=\"4460\"\u003e\n\u003cli data-end=\"4552\" data-start=\"4460\"\u003e\n\u003cp data-end=\"4552\" data-start=\"4463\"\u003eDiscuss the diagnosis and treatment of polycystc ovarian syndrome (PCOS) and amenorrhea\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"4633\" data-start=\"4553\"\u003e\n\u003cp data-end=\"4633\" data-start=\"4556\"\u003eDiscuss diagnosis of male hypogonadism and testosterone replacement therapy\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ol\u003e\n\u003chr data-end=\"4638\" data-start=\"4635\"\u003e\n\u003ch3 data-end=\"4751\" data-start=\"4640\"\u003e\u003cstrong data-end=\"4751\" data-start=\"4644\"\u003e12 – Common Pituitary and Adrenal Conditions Encountered by Primary Care Providers – Dr. Natasa Janicic\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cp data-end=\"4767\" data-start=\"4752\"\u003e\u003cstrong data-end=\"4767\" data-start=\"4752\"\u003eObjectives:\u003c\/strong\u003e\u003c\/p\u003e\n\u003col data-end=\"4911\" data-start=\"4768\"\u003e\n\u003cli data-end=\"4812\" data-start=\"4768\"\u003e\n\u003cp data-end=\"4812\" data-start=\"4771\"\u003eReview pituitary and adrenal physiology\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"4911\" data-start=\"4813\"\u003e\n\u003cp data-end=\"4911\" data-start=\"4816\"\u003eRecognize signs and symptoms of disorders related to pituitary and adrenal hormonal imbalance\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ol\u003e\n\u003cp data-end=\"5345\" data-start=\"5071\"\u003e\u003c\/p\u003e\n\u003cdiv class=\"_tableContainer_1rjym_1\"\u003e\u003c\/div\u003e\n\u003chr data-end=\"2499\" data-start=\"2496\"\u003e\n\u003ch2 data-end=\"2536\" data-start=\"2501\"\u003e🎯 Learning Objectives (Overall)\u003c\/h2\u003e\n\u003cp data-end=\"2566\" data-start=\"2537\"\u003eParticipants will be able to:\u003c\/p\u003e\n\u003cul data-end=\"2907\" data-start=\"2567\"\u003e\n\u003cli data-end=\"2644\" data-start=\"2567\"\u003e\n\u003cp data-end=\"2644\" data-start=\"2569\"\u003eEvaluate rheumatologic disorders including inflammatory\/autoimmune diseases\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"2710\" data-start=\"2645\"\u003e\n\u003cp data-end=\"2710\" data-start=\"2647\"\u003eDifferentiate acute vs chronic gout \u0026amp; crystal-related arthritis\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"2753\" data-start=\"2711\"\u003e\n\u003cp data-end=\"2753\" data-start=\"2713\"\u003eScreen, diagnose \u0026amp; treat thyroid disease\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"2808\" data-start=\"2754\"\u003e\n\u003cp data-end=\"2808\" data-start=\"2756\"\u003eManage obesity and diabetes using updated guidelines\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"2842\" data-start=\"2809\"\u003e\n\u003cp data-end=\"2842\" data-start=\"2811\"\u003eIdentify and treat osteoporosis\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"2907\" data-start=\"2843\"\u003e\n\u003cp data-end=\"2907\" data-start=\"2845\"\u003eSafely use biological therapies for immunocompromised patients\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\u003c\/section\u003e\u003csection class=\"pageContent\"\u003e\u003csection class=\"field_ChildList_Program\"\u003e\n\u003cul class=\"List\" id=\"739a57989b0a9b5b126591ff\"\u003e\u003c\/ul\u003e\n\u003c\/section\u003e\u003c\/section\u003e\n\u003c\/div\u003e","brand":"meducours","offers":[{"title":"Default Title","offer_id":42954507550818,"sku":"MED-AMB04939","price":125.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0662\/9549\/6802\/files\/Screenshot-2025-11-06-220842-768x768_png.webp?v=1779378446","url":"https:\/\/meducourse.com\/products\/mce-endocrinology-and-rheumatology-for-primary-care-2025","provider":"Meducourse","version":"1.0","type":"link"}